Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou AllTest Biotech develops, manufactures, and markets a broad portfolio of in vitro diagnostic products including rapid tests for infectious diseases such as COVID‑19, drugs of abuse panels including fentanyl detection kits, tumor marker assays, cardiac marker tests, veterinary diagnostics, fluorescence immunoassays/analyzers, urine analysis solutions and biochemistry reagents. The company’s products are CE certified with global distribution across North America, Europe, Asia-Pacific and more. They have over nine hundred IVD diagnostic products commercialized.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou AllTest Biotech.